Pain Clinic Doctor and Staff Member Charged with Unlawful Distribution of Opioids
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Pain Clinic Doctor and Staff Member Charged with Unlawful Distribution of Opioids

Pain Clinic Doctor and Staff Member Charged with Unlawful Distribution of Opioids

Enero 06, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 362-3364 - Option 5

TAMPA, Fla. – United States Attorney Roger B. Handberg announced the return of an indictment charging Dr. Qing McGaha (55, Tampa) with conspiracy to commit unlawful distribution of controlled substances and unlawful distribution of controlled substances for no legitimate medical purpose and outside the usual course of professional practice, as well as monetary transactions in criminally derived property. The indictment also charges Camille Mohammed (52, Tampa) with conspiracy to commit unlawful distribution of controlled substances. If convicted of the drug conspiracy count, McGaha and Mohammed each face a maximum penalty of 20 years in federal prison. McGaha also faces a maximum penalty of 20 years in federal prison for each unlawful distribution count (15 counts) and 10 years in federal prison for each money laundering count (4 counts). If convicted on all counts, McGaha and Mohammed each face a maximum penalty of 20 years in federal prison. The indictment also notifies McGaha that the United States intends to forfeit $774,216.12 in U.S. currency, $170,482.34 seized from bank accounts, and two real properties located in the Tampa Bay area, which are alleged to be traceable to proceeds of the offense or used to facilitate the crimes.

According to the indictment, McGaha was a Florida-licensed medical doctor who owned and operated MD Care Clinic, a pain management clinic in Hillsborough County. McGaha employed Mohammed, who served as the clinic’s receptionist and scheduled patient appointments, collected patient fees, and recorded vital measurements. Mohammed also falsified urine screen results, managed the overcrowded waiting room and parking lot, and fielded calls from pharmacists concerned about McGaha’s controlled substance prescriptions.

Over a 20-month period, undercover agents with the Drug Enforcement Administration conducted numerous appointments with McGaha and at each appointment received an opioid controlled substance (hydrocodone, hydromorphone, or oxycodone), not for a legitimate medical purpose and outside the usual course of professional practice.

In addition, McGaha engaged in multiple monetary transactions over $10,000, which monies she criminally derived from the operation of her clinic and which she used to purchase a piece of real property located in Clearwater or deposited into her bank account.

An indictment is merely a formal charge that a defendant has committed one or more violations of federal criminal law, and every defendant is presumed innocent unless, and until, proven guilty.

This case was investigated by the Drug Enforcement Administration Tampa District Office and by the Opioid Fraud Abuse and Detection Unit at the United States Attorney’s Office, which focuses on opioid-related fraud and abuse by medical and health care professionals who have contributed to the prescription opioid epidemic. It will be prosecuted by the United States Attorney’s Office for the Middle District of Florida.

If you are aware of controlled substance violations in your community, please submit your anonymous tip through the DEA online Tip Line at Submit a Tip | DEA.gov.  Concerns about prescription drug abuse or diversion can be reported to the DEA through this link: RX Abuse Online Reporting (usdoj.gov).

Follow DEA Miami via Twitter at @DEAMIAMIDIV.

Download Press Release
###
Hydromorphone Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge - Miami
@deamiamidiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster